Restart Life Sciences Corp.
NMLSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $225 | -$1,224 | -$2,466 | -$2,685 |
| Dep. & Amort. | $2 | $3 | $4 | $5 |
| Deferred Tax | $0 | $0 | $765 | -$112 |
| Stock-Based Comp. | $32 | $353 | $328 | $348 |
| Change in WC | $277 | $4 | -$2 | $630 |
| Other Non-Cash | -$609 | $586 | -$72 | -$133 |
| Operating Cash Flow | -$72 | -$278 | -$1,444 | -$1,946 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $30 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $30 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $75 | $0 | $0 | $0 |
| Stock Issued | $0 | $19 | $1,483 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $19 | $8 | $0 |
| Financing Cash Flow | $75 | $19 | $1,491 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $3 | $716 | $48 | -$1,917 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8 | -$708 | $219 | $2,135 |
| End Cash | $11 | $8 | $267 | $219 |
| Free Cash Flow | -$72 | -$278 | -$1,444 | -$1,946 |